Signifor Solution For Injection 0.3Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

SIGNIFOR: Solution for injection (0.3mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

PASIREOTIDE (PAS i REE oh tide) is used to reduce blood levels of cortisol in patients with a condition called Cushing's disease. It is used when surgery is not an option or has not worked well enough.

In-Depth Information

SIGNIFOR 0.3mg/mL Solution for Injection

NDC: 000780633
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Cushing's Syndrome

Sometimes used for but not FDA approved for the following conditions:
Pancreatic Fistula

Storage Information
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
SIGNIFOR 0.3mg/mL Solution for Injection

Reported Side Effects for SIGNIFOR 0.3mg/mL Solution for Injection

Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Pancreas Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
1.0-8.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
2.0-22.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Lightheadedness Incidence:
2.0-10.0%*
Severity: MILD
Onset: EARLY
High Amylase Levels Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Hair Loss Incidence:
2.0-18.0%*
Severity: MILD
Onset: DELAYED
Low Steroid Hormones Incidence:
2.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
3.0-6.0%*
Severity: MODERATE
Onset: DELAYED
Long Qt Syndrome Incidence:
4.0-6.0%*
Severity: MODERATE
Onset: RAPID
Vomiting Incidence:
4.0-10.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
4.0-14.0%*
Severity: MILD
Onset: EARLY
Weight Loss Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
5.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Low Potassium Levels Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Nervousness Incidence:
6.0-11.0%*
Severity: MILD
Onset: DELAYED
Balance Problems Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Heart Block Incidence:
6.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
6.0-8.0%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
6.0-10.0%*
Severity: SEVERE
Onset: RAPID
Injection Site Reaction Incidence:
7.0-17.0%*
Severity: MILD
Onset: RAPID
Low Blood Pressure Incidence:
7.0%*
Severity: MODERATE
Onset: RAPID
Joint Pain Incidence:
8.0-10.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
8.0-10.0%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Gallstones Incidence:
10.0-33.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
10.0-24.0%*
Severity: MILD
Onset: EARLY
High Cholesterol Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Decreased Appetite Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
24.0-26.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with SIGNIFOR

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5